American Journal of Clinical Dermatology

Article	Citations
Alcohol and Smoking Cessation as Potential Modulators for Smoking-Associated Psoriasis Risk in Postmenopausal Women: The Women’s Health Initiative	238
The Current State of Systemic Therapy of Metastatic Uveal Melanoma	173
New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review	118
Prognostic Biomarkers in Evolving Melanoma Immunotherapy	101
Economic Burden of Chronic Hand Eczema: A Review	99
Role of Inflammation and Cytokine Dysregulation in Depression in Patients with Inflammatory Skin Conditions	93
Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments	91
The Burden of Pediatric Psoriasis: A Systematic Review	91
Disease Duration in Patients Recruited to Psoriasis Phase III Trials: A Systematic Review	91
Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials	84
Performance of Staging Systems for Non-head and Neck Cutaneous Squamous Cell Carcinoma	72
Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don’t Know	66
Predicting the Time to Relapse Following Withdrawal from Different Biologics in Patients with Psoriasis who Responded to Therapy: A 12-Year Multicenter Cohort Study	66
Deciphering the Etiologies of Adult Erythroderma: An Updated Guide to Presentations, Diagnostic Tools, Pathophysiologies, and Treatments	65
Agreement Between Nail Psoriasis Severity Index Scores by a Convolutional Neural Network and Dermatologists: A Retrospective Study at an Academic New York City Institution	64
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroi	61
Obesity in Hidradenitis Suppurativa: Are GLP-1 Receptor Agonists the New Frontier?	61
Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review	61
Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data	61
Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks	61
Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology	57
Pathophysiology of Generalized Pustular Psoriasis	56
Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion	55
Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation	54
Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort Study	53

Comment on: “Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?”	52
Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment	48
Candida Infection Associated with Anti-IL-17 Medication: A Systematic Analysis and Review of the Literature	47
Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD Registry	47
Lessons Learned from Orthopedics: A Call to Action for More Rigorous Platelet-Rich Plasma Hair Loss Clinical Trials	46
Ethnic Differences of Palmoplantar Pustulosis: A Systematic Review	45
Real-World Evidence on Dose Spacing of IL-23 Inhibitors in the Treatment of Psoriasis	45
Disease Modification in Psoriasis: Future Prospects for Long-Term Remission	45
Truncal Acne and Scarring: A Comprehensive Review of Current Medical and Cosmetic Approaches to Treatment and Patient Management	44
A Practice Approach to Acne Fulminans in Adolescents	43
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis	42
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment Hist	41
Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment	41
Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives	41
Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa	40
Patient and Public Involvement in Dermatology Research: A Review	40
Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm	40
The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases	39
A Review of the Etiologies and Key Clinical Features of Secondary Hyperhidrosis	38
Scratching the Surface: A Comprehensive Guide to Understanding and Managing Vulvovaginal Itching	37
Management and Long-Term Outcomes of Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) in Children: A Scoping Review	36
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates	36
Commentary on “Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology”	35
Oral Lichen Planus: An Update on Diagnosis and Management	35
Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, Canada	34
Frontal Fibrosing Alopecia: An Update	33
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History	31
Individualized Neoantigen-Directed Melanoma Therapy	31
The Burden of Acne Vulgaris on Health-Related Quality of Life and Psychosocial Well-Being Domains: A Systematic Review	31
Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists	31
JAK Inhibitors and Inflammatory Nail Disorders: A Systematic Review of Clinical Outcomes and Therapeutic Potential	30
Advancing Precision Medicine in Inflammatory Skin Disease	28
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study	28
Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials	28
Autoimmune and Cutaneous Inflammatory Comorbidities in Adult-Onset Morphea in the All of Us Research Program	27
Targeting Inflammation in Acne: Current Treatments and Future Prospects	27
Comment on: “Eyebrow and Eyelash Alopecia: A Clinical Review”	27
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)	27
Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis	26
Long-Term Safety and Efficacy of Risankizumab to Treat Moderate-to-Severe Plaque Psoriasis: Final LIMMitless Phase 3, Open-Label Extension Trial Results	26
Acknowledgement to Referees	26
Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion	26
Management of Acne in Pregnancy	26
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study	25
Real-World Use of Ruxolitinib Cream: Safety Analysis at 1 Year	25
Cutaneous Small Vessel Vasculitis: A Practical Guide to Diagnosis and Management	25
Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review	24
Burden to Partners of People with Psoriasis: Results from the FamilyPso International Study	24
Intravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective Analysis in 81 Patients	24
Exploring Suzetrigine's Role in Dermatologic Surgery: A Novel Nonopioid Analgesic for Postoperative Pain Management	24

Approach to the Atypical Wound	24
Is There a Place for Biologics in Acne?	23
Impact of Generalized Pustular Psoriasis from the Perspective of People Living with the Condition: Results of an Online Survey	23
Beyond the Herald Patch: Exploring the Complex Landscape of Pityriasis Rosea	23
Treatment Strategies for Chronic Pruritus and Eczema/Dermatitis in Older Adults Under the Category of Chronic Eczematous Eruptions of Aging (CEEA)	22
Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials	22
Autoimmune, Autoinflammatory Disease and Cutaneous Malignancy Associations with Hidradenitis Suppurativa: A Cross-Sectional Study	21
The 25th World Congress of Dermatology, Singapore, 3–8 July, 2023: Research Highlights	21
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations	21
Safety of Hydroxychloroquine: What a Dermatologist Should Know	21
Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort Study	20
Comprehensive and Updated Algorithm of Hidradenitis Suppurativa Management from the Experts	19
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study	19
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2	19
An Update on New and Existing Treatments for the Management of Melasma	19
Review of Laser Treatments for Post-Inflammatory Hyperpigmentation in Skin of Color	19
Correction to: Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”	18
Melanoma Brain Metastases: An Update on the Use of Immune Checkpoint Inhibitors and Molecularly Targeted Agents	18
Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”	18
Real-World Effectiveness, Safety, and Drug Survival of Risankizumab in Adult Patients with Plaque Psoriasis: A 3-Year Multicenter Retrospective Cohort Study	18
Abscopal Effects and Immunomodulation in Skin Cancer Therapy	17
Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies	17
Patient Care Outcomes in Hospitalized Patients with Acute Generalized Exanthematous Pustulosis: A Cross-Sectional Database Study	16
Update in Diagnosis and Management of Primary Cutaneous B-Cell Lymphomas	16
Pharmacokinetics of Roflumilast Cream in Chronic Plaque Psoriasis: Data from Phase I to Phase III Studies	16
Clinical Effectiveness and Safety of Initial Combination Therapy with Corticosteroids and Rituximab in Bullous Pemphigoid: A Retrospective Cohort Study	16
Management of Coexisting Bullous Pemphigoid and Psoriasis: A Review	15
The Skin and Gut Microbiome in Hidradenitis Suppurativa: Current Understanding and Future Considerations for Research and Treatment	15
Correction to: Mastocytosis in the Skin: Approach to Diagnosis, Evaluation, and Management in Adult and Pediatric Patients	15
Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies	15
Atopic Dermatitis Across Shades of Skin	15
Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin	15
Real-World Experience of Bimekizumab for Plaque Psoriasis in Adult Patients with Prior Exposure to Interleukin-23 Inhibitors: A Multicenter Retrospective Study	15
Automated Facial Acne Lesion Detecting and Counting Algorithm for Acne Severity Evaluation and Its Utility in Assisting Dermatologists	15
Treatment of Hyperhidrosis: An Update	15
Lichen Planus: What is New in Diagnosis and Treatment?	14
New Practical Aspects of Sweet Syndrome	14
Lichen Simplex Chronicus: Clinical Perspectives and Emerging Therapeutic Strategies	14
KECORT Study: An International e-Delphi Study on the Treatment of KEloids Using Intralesional CORTicosteroids in Clinical Practice	14
Human Inborn Errors of Immunity in Pyoderma Gangrenosum: A Systematic Review	14
Suggestions for a New Clinical Classification Approach to Panniculitis Based on a Mayo Clinic Experience of 207 Cases	14
Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials	14
Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks	14
Correction to: The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma	14
Alopecia in Children with Cancer: A Review from Pathophysiology to Management	13
Blue Nail Discoloration: Literature Review and Diagnostic Algorithms	13
Meat Allergy: A Ticking Time Bomb	13
Cholestatic Itch: Our Current Understanding of Pathophysiology and Treatments	13
Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis	12
Bimekizumab Complete Clearance of Both Skin and Nail Psoriasis: Comparative Efficacy in Phase III/IIIb Studies	12
Dapsone Use in Dermatology	12
Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis	12
Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview	12
Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial	11
Diagnosis of Generalized Pustular Psoriasis	11
Cellulitis in Pediatric Patients: Recognition and Management in the Era of Evolving Resistance	11
Oral Roflumilast in Patients with Psoriasis: A Real-World Cohort Study	11
Correction to: Adherence to Hidradenitis Suppurativa Treatment	11
Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast	10
Ultrasound Surveillance in Melanoma Management: Bridging Diagnostic Promise with Real-World Adherence: A Systematic Review and Meta-Analysis	10
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments	10
Eyebrow and Eyelash Alopecia: A Clinical Review	10
Management of Erythrodermic Psoriasis with Systemic Therapies: A Systematic Review	10
Alopecia Areata: Current Treatments and New Directions	10
What’s New in Therapy for Male Androgenetic Alopecia?	10
Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program	9
Field Cancerization Therapies for the Management of Actinic Keratosis: An Updated Review	9
Development and Validation of an Artificial Intelligence-Driven Model for Accurate Classification of Erythrodermic Psoriasis Severity: Erythrodermic Psoriasis Integrated Classification System (EPICS)	9
Beyond the Hot Comb: Updates in Epidemiology, Pathogenesis, and Treatment of Central Centrifugal Cicatricial Alopecia from 2011 to 2021	9
Deucravacitinib for the Treatment of Psoriatic Disease	9
Adherence to Hidradenitis Suppurativa Treatment	9
Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy	9
Comment on: “Methotrexate Cutaneous Ulceration: A Systematic Review of Cases”	9
Pruritus in Pregnancy	8
A Guide to the Management of Hidradenitis Suppurativa in Pregnancy and Lactation	8
Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials	8
Development of Cutaneous T-Cell Lymphoma Following Biologic Treatment: A Systematic Review	8
Psychological Therapies and Mind–Body Techniques in the Management of Dermatologic Diseases: A Systematic Review	8
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Cl	8
Association of Cardiovascular Disease and Chronic Spontaneous Urticaria: A Case–Control Study	8

Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial	8
Understanding Enthesitis in Psoriatic Disease: Insights and Implications	8
Psoriasis: Considerations for the Management of Women of Childbearing Potential	8
Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis	8
Publisher Correction to: Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm	8
Relationship of Histopathologic Parameters and Gene Expression Profiling in Malignant Melanoma	8
Maximal Usage Trial of Tapinarof Cream 1% Once Daily in Pediatric Patients Down to 2 Years of Age with Extensive Atopic Dermatitis	7
Evaluating the Longitudinal Course of Atopic Dermatitis: Implications for Clinical Practice	7
Stasis Dermatitis: An Overview of Its Clinical Presentation, Pathogenesis, and Management	7
Clinical Efficacy and Safety of Interleukin-17 Inhibitors in Treating Patients with Erythrodermic Psoriasis: A Retrospective Cohort, Three-Center Study	7
Perioperative Systemic Therapy for High-Risk Cutaneous Squamous Cell Carcinoma	7
Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial	7
Characterization of Clinicopathological Features and Autoantibody Profiles in Patients with Cutaneous Lupus Erythematous: A Single-Center Retrospective Study	6
Hidradenitis Suppurativa: New Targets and Emerging Treatments	6
Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial	6
The Challenge of Treating Anti-PD-1-Resistant Advanced Melanoma	6
Upadacitinib Versus Acitretin for the Resolution of Pustules in Palmoplantar Pustulosis During Acute Phase: A Single-Center, Open-Label Prospective Cohort Study	6
Rare Autoinflammatory Neutrophilic Dermatoses in Pregnancy: Literature Review	6
American Academy of Dermatology Annual Meeting: San Diego, CA, USA, 8–12 March 2024	6
Sequencing of Targeted Therapy in Psoriasis: Does it Matter?	6
Acknowledgment to Referees	6
Classification and Treatment of Angioedema without Wheals: A Spanish Delphi Consensus	6
Determinants and Effectiveness of BNT162b2 mRNA Vaccination Among Patients with Atopic Dermatitis: A Population-Based Study	6
Menopause and Common Dermatoses: A Systematic Review	6
Global Incidence, Mortality, Risk Factors and Trends of Melanoma: A Systematic Analysis of Registries	6
Lactobacillus rhamnosus Used in the Perinatal Period for the Prevention of Atopic Dermatitis in Infants: A Systematic Review and Meta-Analysis of Randomized Trials	6
Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program	6